title: The problem with generic immunosuppressants.
authors.affiliation: Department of Paediatrics, Schulich School of Medicine & Dentistry, London, ON, Canada; Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada; Department of Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada. guido.filler@lhsc.on.ca.
authors.forename: Guido
authors.initials: G
authors.lastname: Filler
authors.forename: Marta
authors.initials: M
authors.lastname: Kobrzyński
mesh_terms: D017277:Drug Approval; D016527:Drug Costs; D016568:Drugs, Generic / Q000737:chemistry / Q000191:economics / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000191:economics / Q000494:pharmacology*; D008004:Licensure; D009173:Mycophenolic Acid / Q000737:chemistry / Q000191:economics / Q000494:pharmacology*; D011355:Prodrugs / Q000737:chemistry / Q000494:pharmacology; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D007166:Immunosuppressive Agents; D011355:Prodrugs; D009173:Mycophenolic Acid